Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5291017
Max Phase: Preclinical
Molecular Formula: C20H26N2
Molecular Weight: 294.44
Associated Items:
ID: ALA5291017
Max Phase: Preclinical
Molecular Formula: C20H26N2
Molecular Weight: 294.44
Associated Items:
Canonical SMILES: c1ccc(CNCCC2CCNC(c3ccccc3)C2)cc1
Standard InChI: InChI=1S/C20H26N2/c1-3-7-18(8-4-1)16-21-13-11-17-12-14-22-20(15-17)19-9-5-2-6-10-19/h1-10,17,20-22H,11-16H2
Standard InChI Key: FRTGDRZWKJSEQS-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 294.44 | Molecular Weight (Monoisotopic): 294.2096 | AlogP: 3.91 | #Rotatable Bonds: 6 |
Polar Surface Area: 24.06 | Molecular Species: BASE | HBA: 2 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.87 | CX LogP: 3.79 | CX LogD: -0.47 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.79 | Np Likeness Score: 0.09 |
1. Fallica AN, Ciaffaglione V, Modica MN, Pittalà V, Salerno L, Amata E, Marrazzo A, Romeo G, Intagliata S.. (2022) Structure-activity relationships of mixed σ1R/σ2R ligands with antiproliferative and anticancer effects., 73 [PMID:36202063] [10.1016/j.bmc.2022.117032] |
Source(1):